|
Philippe Chambon is a Managing Director and founder of New Leaf Venture Partners, a spin-off from The Sprout Group. He joined Sprout in May 1995 and became a General Partner in January 1997. He invests broadly in healthcare technology companies. He currently is on the board of Auxilium Pharmaceuticals (AUXL), NxStage Medical (NXTM) and PharSight (PHST) as well as several private companies.
Previously, Philippe served as Manager in the Healthcare Practice of The Boston Consulting Group from May 1993 to April 1995. From September 1987 to April 1993, he was an executive with Sandoz Pharmaceutical, where he led strategic product development, portfolio management and pre-marketing activities in his capacity as Executive Director of New Product Management. Philippe did graduate research in molecular immunology at The Pasteur Institute and earned a MD, Ph.D. from the University of Paris. Philippe also has an MBA from Columbia University in New York. | 